Impact of a Limosilactobacillus fermentum, Quercetin, and Resveratrol Nutraceutical on Fecal Microbiota Composition and Metabolic Activity in Healthy and Hypertensive Subjects

• Published in: Foods Vol. 14; no. 6; p. 986
• Main Authors: Brasil, Jéssica Maria Alves, Melo, Nathalia Caroline de Oliveira, Sampaio, Karoliny Brito, Costa, Paulo César Trindade da, Duman, Hatice, Karav, Sercan, Lima, Marcos dos Santos, de Souza, Evandro Leite, Alves, José Luiz de Brito
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14.03.2025; MDPI
• Subjects: Acetic acid; bioactive compounds; Blood pressure; Carbohydrates; Composition; Cytotoxicity; Digestive system; Enzymes; Ethanol; Fecal microflora; Feces; Fermentation; Fructooligosaccharides; Fructose; Functional foods; Functional foods & nutraceuticals; Gastrointestinal tract; Health care; Hypertension; intestinal microbiota; Intestinal microflora; Lactic acid; Lymphocytes T; Maltose; Metabolism; Metabolites; Microbiomes; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Organic acids; prebiotic; Prebiotics; probiotic; Probiotics; Quercetin; Relative abundance; Resveratrol; Small intestine; Succinic acid; Sugars; T cells; United States; Massachusetts; Brazil; United States > US; intestinal microbiota; bioactive compounds; probiotic; prebiotic; hypertension

A promising strategy to improve the gut microbiome in hypertension is to target the gut microbiota. This study evaluated the effects of a potential nutraceutical product composed of three strains of Limosilactobacillus (L.) fermentum, quercetin, and resveratrol on the intestinal microbiome of health...